ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD), sponsored by ARYA Sciences Holdings IV — an affiliate of Perceptive Advisors, the healthcare-focused investment firm led by Joseph Edelman — was a blank-check company that completed its initial public offering in 2021 targeting the life sciences and biopharmaceutical sector. The vehicle was the fourth in a series of ARYA Sciences SPACs, each aimed at identifying emerging healthcare and biotechnology targets. ARYD filed a Form 15-12G with the SEC on August 12, 2024, signaling the termination of its Exchange Act Section 12(g) registration and confirming the SPAC wound down without closing a business combination. For complete filing history, deal timelines, and sponsor analytics on ARYD and hundreds of other SPACs, sign up for full data access at SpacDesk.